Original Query: ALL
Previous Study | Return to List | Next Study

Efficacy and Safety of Simtuzumab With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01479465
Recruitment Status : Completed
First Posted : November 24, 2011
Last Update Posted : March 30, 2015
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2014
  Study Completion Date : February 2015
  Certification/Extension First Submitted : March 10, 2015